Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Cerebral Palsy in Subjects Above Years (BMACCP) .It is Self Funded (Patients' Own Funding) Clinical Trial

NCT01834664 is registered in ClinicalTrials.gov with Chaitanya Hospital, Pune as lead sponsor.

NCT NCT01834664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01834664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Cerebral Palsy in Subjects Above Years (BMACCP) .It is Self Funded (Patients' Own Funding) Clinical Trial
Lead sponsor
Chaitanya Hospital, Pune
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 31, 2013
Completion date
June 30, 2016
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ataxic infantile cerebral palsy